NorthShore Bio has created a scalable chip-based platform with solid-state "tunable" nanopores that it plans to develop for DNA and RNA sequencing applications using a sequencing-by-degradation approach.

Last week, the firm, which is based in the Portland, Oregon metropolitan area but uses lab space at the Institute for Systems Biology in Seattle, became a winner of this year's TiE50 annual awards program, which honors 50 technology startups selected from more than 1,000 entries.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.